Genetic testing in the epilepsies-developments and dilemmas
- PMID: 24733164
- PMCID: PMC4090104
- DOI: 10.1038/nrneurol.2014.60
Genetic testing in the epilepsies-developments and dilemmas
Abstract
In the past two decades, the number of genes recognized to have a role in the epilepsies has dramatically increased. The availability of testing for epilepsy-related genes is potentially helpful for clarification of the diagnosis and prognosis, selection of optimal treatments, and provision of information for family planning. For some patients, identification of a specific genetic cause of their epilepsy has important personal value, even in the absence of clear clinical utility. The availability of genetic testing also raises new issues that have only begun to be considered. These issues include the growing importance of educating physicians about when and how to test patients, the need to ensure that affected individuals and their families can make informed choices about testing and receive support after receiving the results, and the question of what the positive and negative consequences of genetic testing will be for affected individuals, their family members, and society.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Thomas RH, Berkovic SF. The hidden genetics of epilepsy—a clinically important new paradigm. Nat Rev Neurol. http://dx.doi.org/10.1038/nrneurol.2014.62. - DOI - PubMed
-
- Pal DK, Pong AW, Chung WK. Genetic evaluation and counseling for epilepsy. Nat Rev Neurol. 2010;6:445–453. - PubMed
-
- Pong AW, Pal DK, Chung WK. Developments in molecular genetic diagnostics: an update for the pediatric epilepsy specialist. Pediatr Neurol. 2011;44:317–327. - PubMed
-
- Hirose S, et al. SCN1A testing for epilepsy: application in clinical practice. Epilepsia. 2013;54:946–952. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous